Skip to main content

Table 2 Barriers to target identification referenced across studies

From: Individualized mean arterial pressure targets in critically ill patients guided by non-invasive cerebral-autoregulation: a scoping review

Category

Issue

N of studies

Measures taken or recommended

Impact on study or clinical application*

Data acquisition

TCD

Anomalous/contaminated data (e.g., movement, electrocautery, physiologically impossible velocity)

7

Manual removable of artifacts, utilize only unilateral recordings, or patient exclusion

In cardiac surgery, this affects pre/post-CPB periods more due to high electrocautery activity. Patient attrition and signal loss related to this cause were up to 23% [51] and 36% respectively [60]. In brain injury, attrition rate related to this cause was 7% [33]. Manual removal might not perfectly rule out contaminated signals. [52, 56, 57, 62]

Lack of transcranial window

4

Patient exclusion

Minimally impacts recruitment rate (4–7% of recruited patients) and could be identified early in the research

[33, 61,62,63]

Forehead obstruction (e.g., monitors, dressing, hemicraniectomy)

1

Patient exclusion or use only unilateral recordings

Specific prevalence was not reported [33]

NIRS

Contaminated signals (metabolic/physiological changes incompatible with the recording mechanism)

2

Patient exclusion

Patient attrition related to this cause was few (6%)[53]; could be inherent to the technology thereby impact is masked, specific populations might be more affected and should be identified [44]

5/6/2025 7:19:00 PM

Sensor adhesion issues

1

Remove recordings

Specific prevalence was not reported [39]

Optode malfunction

1

Patient exclusion or use only unilateral recordings

Affected 1% of patients [38]

Recording failure

1

Specific prevalence was not reported [37]

Equipment unavailability

1

Specific prevalence was not reported [40]

MAP

Anomalous or contaminated data

3

Manual or auto/algorithmic MAP cleaning

Affected up to 15% of participants [40, 41, 43]

Software failure (loss of continuous MAP data)

1

Patient exclusion and data cleaning

Affected up to 23% participants [62]

Other or unspecified

Equipment unavailability, no high-fidelity recording, data loss while transferring, or protocol miscommunication

4

Patient exclusion, re-training and equipping sites, extract data immediately after recording, review protocol and improve documentation

Affected 3% to 53% of eligible participants depending on when the protocol is reviewed and revised [37, 40, 43, 48]

Anomalous or contaminated data

3

Data cleaning or patient exclusion

Affected 14% of data recorded [37] and 23–26% of participants [55, 58]

Damaged recordings or other recording complications

2

Patient exclusion

Affected 9% [45] and 4% of all eligible participants [37]

ICU discharge before study completion

1

Modify study design/timing

Specific prevalence was not reported [48]

Target calculation

 

No observable MAP limits—MAP always above/outside acceptable thresholds

15

Define LLA as the lowest COx above the threshold, adjusting threshold values

Affected 2–100% participants depending on study methods. Gergelé et al.[52] tried calculating LLA with 15-min long recording and was unsuccessful. Møller et al.[35] tried calculating LLA in patients with bacterial meningitis in the first 24 h after diagnostic lumbar puncture and was also unsuccessful until later in their recovery. Asides from these two studies, loss related to this cause is lower than 35%. Yield appears lower for ULA vs LLA [29]. [33, 43,44,45, 49, 51, 53, 54, 63, 65,66,67]

No observable MAP limits—MAP always below/within acceptable thresholds

7

No steps needed as assumed part of healthy variation; prevalence should be transparently reported

Affected 2–60% of participants, regression studies more heavily affected; threshold values influenced detection rates; surgical studies generally had better identification rates than ICU studies (2–18% loss versus 26–27% [correlation approach only]) [29, 43, 49, 53, 54, 63, 67]

Short recording duration

5

Attempts made to calculate but if unsuccessful patients will be excluded

Affected 10% of participants [33, 34, 38, 44, 54]

Fluctuating thresholds

1

N/A

Affected 15% (Mx2s) and 16% (Mx10s) of participants [51]

  1. *Prevalence only cited if directly identified as associated with listed causes in the table. Sometimes the prevalence of the issue is aggregated with other causes. In these cases, we decided not to report the aggregated prevalence to not misinterpret the findings